New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
15:18 EDTRPRXRepros Therapeutics price target raised to $25 from $18 at Ladenburg
Ladenburg raised Repros price target following positive Phase III data from its pivotal trial of Androxal ZA-301. Shares are Buy rated.
News For RPRX From The Last 14 Days
Check below for free stories on RPRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RPRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use